Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Depersonalization
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Biological === Studies have linked dysregulation of the [[immune system]] with depersonalisation.<ref>{{Cite journal |last=Zheng |first=Sisi |last2=Feng |first2=Sitong |last3=Song |first3=Nan |last4=Chen |first4=Guangyao |last5=Jia |first5=Yuan |last6=Zhang |first6=Guofu |last7=Liu |first7=Min |last8=Li |first8=Xue |last9=Ning |first9=Yanzhe |last10=Wang |first10=Dan |last11=Jia |first11=Hongxiao |date=2024-05-27 |title=The role of the immune system in depersonalisation disorder |url=https://www.tandfonline.com/doi/full/10.1080/15622975.2024.2346096 |journal=The World Journal of Biological Psychiatry |language=en |volume=25 |issue=5 |pages=291β303 |doi=10.1080/15622975.2024.2346096 |issn=1562-2975|url-access=subscription }}</ref> Researchers compared protein expression in serum samples of individuals with [[Depersonalization-derealization disorder|depersonalisation/derealization disorder]] (DPDR, DDD) and healthy controls, and found that many key proteins involved in maintaining [[homeostasis]] were present at altered levels. Decreased levels of [[C-reactive protein|C-reactive protein (CRP)]], [[Complement component 1q|complement C1q subcomponent subunit B]], and apolipoprotein A-IV, and increased levels of alpha-1-antichymotrypsin (SERPINA3) were observed in patients with DPDR. Furthermore, expressions of CRP and SERPINA3 were found to be linked with the ability to inhibit cognitive interference of DPDR.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)